Nitazoxanide pharmacokinetics and tolerability in man using single ascending oral doses
about
Nitazoxanide for chronic hepatitis CNitazoxanide for chronic hepatitis C virus infectionNitazoxanide, a broad-spectrum thiazolide anti-infective agent for the treatment of gastrointestinal infectionsNitazoxanide: a review of its use in the treatment of gastrointestinal infectionsBiochemical, mutational and in silico structural evidence for a functional dimeric form of the ornithine decarboxylase from Entamoeba histolyticaNitazoxanide stimulates autophagy and inhibits mTORC1 signaling and intracellular proliferation of Mycobacterium tuberculosisGiardiasis: a pharmacotherapy review.Thiazolides: a new class of drugs for the treatment of chronic hepatitis B and C.Thiazolides: a new class of antiviral drugs.Nitazoxanide: clinical studies of a broad-spectrum anti-infective agent.In Vitro Susceptibility of Canine Influenza A (H3N8) Virus to Nitazoxanide and Tizoxanide.The pharmacokinetics of nitazoxanide active metabolite (tizoxanide) in goats and its protein binding ability in vitro.Nitazoxanide: a new thiazolide antiparasitic agent.Susceptibilities of MDR Mycobacterium tuberculosis isolates to unconventional drugs compared with their reported pharmacokinetic/pharmacodynamic parameters.
P2860
Q24197485-E115939C-87BE-40DC-B491-0108E4D7FCFAQ24234215-E5CDFD98-EA0B-4181-95D5-09665F13D786Q28236279-D9C49176-1D3C-40F7-89B7-33944C2E098AQ28242385-82E3EAD3-8916-4B35-9254-755C7B1C94A4Q28481304-B192D437-22A5-4388-B17D-029C33A61BFAQ28483646-54519A83-E6A3-46F6-B201-B81BCD6E57FCQ36909277-28B199D6-E1CA-48B6-8B07-20B7C1B3413AQ37277077-4C62ADCA-EA82-4071-88A7-1661EA1A8F95Q37481436-31C7855E-0453-471F-A0CF-FACAC481942EQ40149924-277BEB04-6899-48EF-91BA-EB3F56B7E608Q42430401-3D4497DC-F9D7-43A3-91E1-A0D489AC2A22Q42659553-CC5677B9-DF4E-42BC-B044-7280B3C4452DQ46404981-4F8A574E-6485-4788-9C41-A863B1AFDB64Q50780166-1D718A52-3440-408A-81D7-D947EA8C548F
P2860
Nitazoxanide pharmacokinetics and tolerability in man using single ascending oral doses
description
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
article
@en
im Mai 2002 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel (gepubliceerd op 2002/05/01)
@nl
наукова стаття, опублікована в травні 2002
@uk
مقالة علمية (نشرت في مايو 2002)
@ar
ലേഖനം
@ml
name
Nitazoxanide pharmacokinetics and tolerability in man using single ascending oral doses
@ast
Nitazoxanide pharmacokinetics and tolerability in man using single ascending oral doses
@en
type
label
Nitazoxanide pharmacokinetics and tolerability in man using single ascending oral doses
@ast
Nitazoxanide pharmacokinetics and tolerability in man using single ascending oral doses
@en
prefLabel
Nitazoxanide pharmacokinetics and tolerability in man using single ascending oral doses
@ast
Nitazoxanide pharmacokinetics and tolerability in man using single ascending oral doses
@en
P2093
P356
P1476
Nitazoxanide pharmacokinetics and tolerability in man using single ascending oral doses
@en
P2093
A. Stockis
A.-M. Allemon
C. Gengler
S. De Bruyn
P304
P356
10.5414/CPP40213
P577
2002-05-01T00:00:00Z